Safety and efficacy of tiranizumab combined with chemotherapy in advanced NSCLC patients
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Tislelizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Aug 2020 New trial record